FRIDAY, DECEMBER 14, 2018

Transcription

1 FRIDAY, DECEMBER 14, :00 am Day Two Welcome Ash Tewari, MBBS, MCh RADICAL PROSTATECTOMY Panelists: Arul Chinnaiyan, MD, PhD; Douglas Scherr, MD; Prasanna Sooriakumaran, MD, PhD; Ofer Yossepowitch, MD 7:10 am Chasing Complications Following RALP Francesco Montorsi, MD 7:25 am Outcome of Delayed Radical Prostatectomy in Those Managed Initially with Active Surveillance Peter Carroll, MD 7:35 am Radical Prostatectomy in Oligometastatic Disease: Experience from the UK RCT TRoMbone Prasanna Sooriakumaran, MD, PhD 7:50 am BREAK / VISIT EXHIBITS 8:00 am 3D Live Surgery: Robot Assisted Radical Prostatectomy Surgeon: Ash Tewari, MBBS, MCh Moderators: Ketan K. Badani, MD; Alberto Martini, MD Panelists: Arie Belldegrun, MD; Michael Cookson, MD; Reza Ghavamian, MD; Francesco Porpiglia, MD 9:30 am Role of Surgery in Advanced Disease and Salvage Lymph Node Dissections Vincent Laudone, MD 9:40 am Management of Lymph Node Positive Prostate Cancer and Neoadjuvant Systemic Therapy in Localized Prostate Cancer Brian Chapin, MD 9:55 am The Role Local Therapy in Oligometastatic PCa Markus Graefen, MD 10:10 am Cytoreductive Radical Prostatectomy in Men with M1a or M1b Disease Isaac Kim, MD, PhD 10:20 am 3D Image-Guided Surgery in Prostate Cancer: From Cognitive to Augmented Reality Procedures Francesco Porpiglia, MD Page 1/15

2 10:35 am Outpatient Prostatectomy David Lee, MD 10:45 am Retzius-Sparing Trans-Douglas Radical Prostatectomy Markus Hohenfellner, MD 11:00 am Orgasmic Dysfunction following RARP 11:15 am Less is More for Prostate Cancer Abhay Rane, OBE 11:30 am Salvage vs Adjuvant RT After Prostatectomy, Including the Role of Genomic Testing Michael Herman, MD 11:40 am Perineal Robotic Prostatectomy Jihad Kaouk, MD 11:55 am Q&A (Radical Prostatectomy) 12:05 pm LUNCH SYMPOSIUM 1:05 pm How to Change the Field of Medicine Ralph Clayman, MD 1:35 pm Q&A (How to Change the Field of Medicine) 1:40 pm Biomarkers and Immunotherapy Susan F. Slovin, MD, PhD 1:50 pm Precision Focal Prostatectomy Mani Menon, MD 2:00 pm Q&A 2:05 pm The Online Urologist: From Separating Signal Noise in Keeping with Research, to Boosting Referrals, Social, Mobile, and Machine Learning Technologies are Transforming Medicine Nate Gross, MD 2:20 pm Q&A (The Online Urologist) 2:23 pm The QOL Comparison between Open vs Robotic Prostatectomy Page 2/15

3 Mishop Han, MD SURS SESSION Single Port Robotic Panel Panelists: Ketan Badani, MD, Daniel Eun, MD, Jihad Kaouk, MD, Ash Tewari, MBBS, MCh, TBD 2:33 pm TITLE TBD 3:03 pm Q&A SEXUAL HEALTH FOLLOWING PROSTATECTOMY Panelists: Natan Bar-Chama, MD, Barbara Chubak, MD, Doron Stember, MD, Robert Valenzuela, MD, and 3:13 pm Orgasmic Dysfunction following RARP 3:28 pm Stem Cells and Cytokines: Hope or Hype?: reviewing the evidence for the use of these for prophylaxis against and treatment of post-prostatectomy ED Barbara Chubak, MD 3:43 pm Treatment of Male Hypogonadism using Non-Testosterone Therapies Natan Bar-Chama, MD 3:58pm Sexual Function after RALP Doron Stember, MD 4:13 pm Emerging Treatment Options for Post Prostactomy Climacturia Robert Valenzuela, MD 4:28 pm Afternoon Session II: Superstars in Oncology Location: TBD Closing Remarks Ash Tewari, MBBS, MCh Page 3/15

4 FRIDAY, DECEMBER 14, 2018 BREAKOUT SESSION II: IMMUNOTHERAPY & TUMOR MICROENVIRONMENT (PART II) Moderators: Jeffrey Bockman, PhD; Daniel Petrylak, MD 1:05 pm Management of Incontinence after Radiation or Surgery Rajveer S. Purohit, MD 1:15 pm Q&A (Management of Incontinence after Radiation or Surgery) 1:18 pm Gene-Oncogene Interactions Carlos Cordon-Cardo, MD, PhD 1:28 pm Q&A (Gene-Oncogene Interactions) 1:31 pm Current Status of Immune Therapy for Prostate Cancer Daniel Petrylak, MD 1:41 pm Q&A (Current Status of Immune Therapy for Prostate Cancer) 1:44 pm Linking Scientific and Clinical Issues to Commercial/Strategic Considerations Jeffrey Bockman, PhD 1:54 pm Q&A (Linking Scientific and Clinical Issues to Commercial/Strategic Considerations) 1:57 pm Oligometastases and New Therapies for Bone Metastatic Prostate Cancer Alexander Kirschenbaum, MD 2:07 pm Q&A (Oligometastases and New Therapies for Bone Metastatic Prostate Cancer) 2:10 pm Novel Therapeutic Targeting of Advanced Cancer Natasha Kyprianou, PhD 2:20 pm Q&A (Novel Therapeutic Targeting of Advanced Cancer) 2:23 pm Tumor Suppressor, PTEN s Role in Prostate Cancer Progression Sait Ozturk, PhD 2:33 pm Q&A (Tumor Suppressor, PTEN s Role in Prostate Cancer Progression) 2:36 pm Urinary Adverse Events After Prostate Cancer Treatment (RP, RT, etc.) Jaspreet Sandhu, MD Page 4/15

5 2:46 pm Q&A (Urinary Adverse Events After Prostate Cancer Treatment) 2:49 pm Robotic Post Chemotherapy RPLND James Porter, MD 2:59 pm Q&A (Robotic Post Chemotherapy RPLND) 3:02 pm Science that Underlies Prostate Cancer Racial Disparity Isaac Powell, MD 3:12 pm Q&A (Science that Underlies Prostate Cancer Racial Disparity) 3:15 pm Teamwork and Safety Conversations to Prevent Wrong Site Surgery Amanda Rhee, MD 3:25 pm Q&A (Teamwork and Safety Conversations to Prevent Wrong Site Surgery) 3:28 pm Socioeconomic Implications of Prostate Cancer Therapy Deepak Kapoor, MD 3:38 pm Q&A (Socioeconomic Implications of Prostate Cancer Therapy) 3:41 pm JOIN THE MAIN SESSION Page 5/15